Menu
ncarol.com
  • Home
  • Business
  • Financial
  • Yacht Buyer
  • Nyse
  • Banking
  • Stocks
  • Finance
  • Education
ncarol.com

Lineus Medical Receives Patent for SafeBreak® Vascular Generation 2
ncarol.com/10314150

Trending...
  • National Expansion Ignited Across Amazon $AMZN, Chewy $CHWY & Walmart $WMT: NDT Pharmaceuticals, Inc. (Stock Symbol: NDTP) $NDTP
  • Elder Abuse Case Against Healthy Traditions Owner Raises Questions As To The Dire Reality Of Abuse Against The Last Of The Baby Boomers
  • Pure Energy Electrical Services, LLC Announces Strong Start to 2026, Reinforcing Customer-First Electrical Service Across Northeast Florida
SafeBreak Generation 2 Patent Lineus Medical
FAYETTEVILLE, Ark. - ncarol.com -- Lineus Medical, the leader in vascular access innovation, has been awarded a U.S. patent for SafeBreak® Vascular Generation 2, the next evolution of the company's flagship breakaway device. The newly patented design features a single-valve system, replacing the original device's two-valve configuration. The ideas captured in the patent allow the device to have a significantly smaller profile while maintaining the device's core function of protecting IV lines from damaging external forces by separating. The patent also includes the ability to add a light and/or sound notification for nurses when the device separates. The current version of SafeBreak relies on IV pump alarm to alert nurses of a separation. Having an alarm on SafeBreak will help open up the home healthcare and gravity line IV market for the company.

SafeBreak Vascular is the only breakaway device for IV lines clinically proven to reduce multiple IV complications.¹ When a damaging force is placed on the line, SafeBreak intentionally separates to remove the force and protect the patient's IV.   When separation occurs, valves on both ends of the device close to prevent medication leakage from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patent's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money.1

More on ncarol.com
  • Cleveland County Families Choosing to Restore Quality Furniture Instead of Buying New
  • Strong Clinical Results for Breakthrough Liver Diagnostic Platform; ENDRA Life Sciences (N A S D A Q: NDRA) $NDRA
  • 46th International Symposium On Forecasting – Dates, Venue And Speakers Announced
  • Phoenix Rebellion Therapy Celebrates 10 Years Helping Utahns Overcome Trauma as Utah Faces Nation's 2nd-Highest Rate of Mental Health Challenges
  • Bonavita Luxury & Portable Lavatories Announces Rebrand to Bonavita Site Solutions

"Lineus Medical continues to innovate and be the thought leader both clinically and scientifically in the breakaway device market.", said Vance Clement, CEO of Lineus Medical. "SafeBreak Gen 2 will move us closer to accomplishing our mission of removing the pains associated with IV lines for patients, nurses, and hospitals."

"The SafeBreak Gen 2 design reflects our ongoing commitment to the continuous improvement of SafeBreak," said Will Armstrong, COO of Lineus Medical. "This patent showcases how our engineering team is advancing breakaway device technology with smarter, simpler design solutions that improve patient care while further strengthening the company's intellectual property portfolio."

About Lineus Medical

Lineus Medical is the developer of SafeBreak® Vascular, a breakaway technology proven to reduce IV restarts and IV complications.¹ More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Facebook, and Instagram.

References:

1. Data on file.

Contact
Vance Clement
***@lineusmed.com


Source: Lineus Medical

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Legendary broadcaster & cultural influencer Beatrice Thompson sat down with hosts of The Game Has E
  • Elder Abuse Case Against Healthy Traditions Owner Raises Questions As To The Dire Reality Of Abuse Against The Last Of The Baby Boomers
  • Simpalm Staffing Services Launched its Refreshed Website for Remote Staffing Services
  • Claude Riveloux Review 2026: How the $10B Fund Manager Dispels 'Scam' Rumors Through Education
  • Pure Energy Electrical Services, LLC Announces Strong Start to 2026, Reinforcing Customer-First Electrical Service Across Northeast Florida
  • Danholm Collection Launches Boutique Luxury Real Estate Brokerage in Central Florida
  • Sellvia Market Expands Curated Store Portfolio for Dropshipping Sellers
  • Food Journal Magazine Raises the Standard for Restaurant Reviews in Los Angeles
  • Call for Nominations for the 2027 Paul E Garber First Flight Shrine
  • Williamsville Spa Expands Team to Meet Growing Demand for Professional Facials
  • Pregis Expands Wind Energy Use, Advancing Progress Toward Net Zero by 2040
  • Dr. Sheel Desai Solomon and Preston Dermatology Continue Awards Streak with Top Honors in 2026 Maggy Awards
  • Jack and Sage Acquires Sustainable Apparel Brand Kastlfel, Expanding Premium Logo Wear Across National Parks and Ski Resorts
  • Cancun International Airport Prepares for Record Travel Surge Ahead of Spring Break, Summer, and the 2026 High Season
  • $167 Billion Pharma R&D Market Largely Untapped by AI Creates Major Growth Runway for KALA Bios Data-Sovereign AI Strategy: N A S D A Q: KALA
  • Lighthouse Tech Awards Recognize Top HR Technology Providers for 2026
  • ADB Selects OneVizion to Advance Field Execution and Infrastructure Program Management
  • Memelinked Social Media powered by cryptocurrency launching July 2026
  • DwellSafe and Bruno Partner to Bring Clinician-Backed Stairlift Education to Families
  • Seven-Year-Old Toronto Dancer Julianna Selivanov Wins Nine Medals at Quebec Championship and Reaches Finals at UK Dance Festival
_catLbl0 _catLbl1

Popular on ncarol.com

  • Finland's €1.3 Billion Digital Gambling Market Faces Regulatory Tug-of-War as Player Protection Debate Intensifies - 120
  • Still Using Ice? FrostSkin Reinvents Hydration - 107
  • François Arnaud, star of Heated Rivalry, is the real-life inspiration behind Christopher Stoddard's novel At Night Only
  • Purple Heart Recipient Honored by Hall of Fame Son In Viral Tribute Sparking National Conversation on Service Fatherhood, Healing and Legacy
  • Diversified Roofing Solutions Strengthens Industry Leadership With Expanded Roofing Services Across South Florida
  • General Relativity Challenged by New Tension Discovered in Dark Siren Cosmology
  • Cold. Clean. Anywhere. Meet FrostSkin
  • High-Margin Energy & Digital Infrastructure Platform Created after Merger with Established BlockFuel Energy, Innovation Beverage Group (NAS DAQ: IBG)
  • Conexwest Delivers Custom Shipping Container MRI Lab, Saving California Hospital an Estimated $9 Million in Renovation Costs
  • Lineus Medical's SafeBreak® Vascular Added to Alliant GPO Contract

Similar on ncarol.com

  • Quadcode Acquires Significant Stake in Game 7, LLC - The Parent Company for FPFX Tech and PropAccount.com
  • Phoenix Rebellion Therapy Celebrates 10 Years Helping Utahns Overcome Trauma as Utah Faces Nation's 2nd-Highest Rate of Mental Health Challenges
  • Pregis Expands Wind Energy Use, Advancing Progress Toward Net Zero by 2040
  • Dr. Sheel Desai Solomon and Preston Dermatology Continue Awards Streak with Top Honors in 2026 Maggy Awards
  • $167 Billion Pharma R&D Market Largely Untapped by AI Creates Major Growth Runway for KALA Bios Data-Sovereign AI Strategy: N A S D A Q: KALA
  • Lighthouse Tech Awards Recognize Top HR Technology Providers for 2026
  • ADB Selects OneVizion to Advance Field Execution and Infrastructure Program Management
  • Leoforce Releases Beyond Programmatic: A Practical Guide to Long-Term Hiring Outcomes
  • Progressive Dental & The Closing Institute Partner with Zest Dental Solutions to Elevate Full-Arch Growth and Patient Outcomes
  • Serina Damesworth Hired as Century Fasteners Corp. – Director of Quality
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute